Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nose to brain delivery of Rotigotine loaded solid lipid nanoparticles: Quality by design based optimization and characterization
Jagruti B. Prajapati, Gayatri Patel
Journal of Drug Delivery Science and Technology (2021) Vol. 63, pp. 102377-102377
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Novel Nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson’s symptoms management: In vitro and in vivo evaluation in a rotenone-induced rat model
Hisham A. Nematalla, Mona Elharoun, Somaia N Bargash, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125197-125197
Closed Access | Times Cited: 2
Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study
Mohd Yasir, Ameeduzzafar Zafar, K.M. Noorulla, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103631-103631
Closed Access | Times Cited: 47
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Paramita Saha‐Chaudhuri, Himanshu Kathuria, Murali Monohar Pandey
Journal of Controlled Release (2023) Vol. 358, pp. 293-318
Closed Access | Times Cited: 30
Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation
Ameeduzzafar Zafar, Omar Awad Alsaidan, Nabil K. Alruwaili, et al.
International Journal of Pharmaceutics (2022) Vol. 627, pp. 122232-122232
Closed Access | Times Cited: 36
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 32
Research progress on intranasal treatment for Parkinson's disease
Puyuan Wen, Chao Ren
Neuroprotection/Neuroprotection (Chichester, England. Print) (2024) Vol. 2, Iss. 2, pp. 79-99
Open Access | Times Cited: 6
The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery
Laura Deruyver, Clément Rigaut, Pierre Lambert, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113826-113826
Open Access | Times Cited: 34
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
Aline de Alcântara Correia, João Nuno Moreira, José Manuel Sousa Lobo, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1731-1748
Closed Access | Times Cited: 14
Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices
Devendra Birla, Nikhil Khandale, Bushra Bashir, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 5
Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application
António Correia, Inês Costa, Rui Silva, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124631-124631
Open Access | Times Cited: 4
Pegylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS
Arya Bazargani, Mohammad Hejazi, Matthew Fernandez, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125166-125166
Closed Access
Recent Advances in Rotigotine Nanoformulations for Parkinson’s Disease Therapy
Sanchit Arora, Dalapathi Gugulothu
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Intranasal Poly(Lactic-co-Glycolic Acid) Nanoparticles of Mefenamic Acid Improve Motor Expressions and Neurochemical Injury in Aluminium Chloride Originated Alzheimer’s Disease
Anmol Dogra, Ramandeep Singh Narang, Tajpreet Kaur, et al.
Journal of Cluster Science (2025) Vol. 36, Iss. 3
Closed Access
Apolipoprotein E3 functionalized mesoporous silica nanoparticles for targeted and enhanced therapeutic efficacy of Levetiracetam in brain tumor-associated epilepsy: Insights into brain uptake, biodistribution and pharmacokinetic behavior
Mansi Athalye, Mehul R. Chorawala, Abhilasha Sharma, et al.
International Journal of Biological Macromolecules (2025), pp. 143174-143174
Closed Access
Nose-to-brain delivery of rotigotine redispersible nanosuspension: In vitro and in vivo characterization
Paramita Saha, Himanshu Kathuria, Murali Monohar Pandey
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104049-104049
Open Access | Times Cited: 18
Intranasal repaglinide-solid lipid nanoparticles integrated in situ gel outperform conventional oral route in hypoglycemic activity
Soha M. Elkarray, Ragwa M. Farid, Mohammad M. Abd‐Alhaseeb, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 68, pp. 103086-103086
Closed Access | Times Cited: 16
Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts
Sandra Aulia Mardikasari, Bence Sipos, Ildikó Csóka, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103887-103887
Closed Access | Times Cited: 13
Development of hyaluronic acid-based microneedles for improved brain delivery of rivastigmine nanoparticles via mystacial pad region
Andi Dian Permana, Anugerah Yaumil Ramadhan Aziz, Anwar Sam, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 90, pp. 105183-105183
Closed Access | Times Cited: 7
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade
Mahitab Bayoumi, John Youshia, Mona G. Arafa, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 2
Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route
Joana Torres, Renata Silva, Gonçalo Farias, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1297-1297
Open Access | Times Cited: 2
A Combinatorial Approach with Microneedle Pretreatment and Thermosensitive Gel Loaded with Rivastigmine Lipid Nanoparticle Formulation Enables Brain Delivery via the Trigeminal Nerve
Andi Dian Permana, Muhammad Alif Sya’ban Mahfud, Miftakhul Munir, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 49, pp. 68388-68406
Closed Access | Times Cited: 2
Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review
Archita Kapoor, Abdul Hafeez, Poonam Kushwaha
Current Drug Delivery (2023) Vol. 21, Iss. 5, pp. 709-725
Closed Access | Times Cited: 4
Apolipoprotein E3 functionalized lipid-drug conjugated nanoparticles of Levetiracetam for enhanced delivery to the brain: In-vitro cell line studies and in-vivo study
Mansi Athalye, Divya Teli, Mehul R. Chorawala, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127799-127799
Closed Access | Times Cited: 4
Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review
Afiya Furquan, Abdul Hafeez, Md. Azizur Rahman
Journal of Nanoparticle Research (2023) Vol. 25, Iss. 11
Closed Access | Times Cited: 4
Tiny Carriers, Tremendous Hope: Nanomedicine in the Fight against Parkinson’s
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare
Journal of dementia and Alzheimer's disease (2024) Vol. 1, Iss. 1, pp. 3-21
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top